|
Volumn 24, Issue 3, 2013, Pages 495-499
|
Significance of panel reactive antibodies in patients requiring kidney transplantation.
a a
a
not available
*
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLOANTIBODY;
BIOLOGICAL MARKER;
HLA ANTIGEN;
ADOLESCENT;
ADULT;
ARTICLE;
BLOOD;
CASE CONTROL STUDY;
CHRONIC KIDNEY FAILURE;
DIAGNOSTIC KIT;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EQUIPMENT;
FEMALE;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY;
HISTOCOMPATIBILITY TEST;
HOSPITAL ADMISSION;
HUMAN;
IMMUNOLOGY;
KIDNEY TRANSPLANTATION;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
PREDICTIVE VALUE;
RISK FACTOR;
TERTIARY HEALTH CARE;
TIME;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
BIOLOGICAL MARKERS;
CASE-CONTROL STUDIES;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY;
HISTOCOMPATIBILITY TESTING;
HLA ANTIGENS;
HUMANS;
ISOANTIBODIES;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
REAGENT KITS, DIAGNOSTIC;
RISK FACTORS;
TERTIARY CARE CENTERS;
TIME FACTORS;
TREATMENT OUTCOME;
WAITING LISTS;
YOUNG ADULT;
|
EID: 84879313896
PISSN: 13192442
EISSN: None
Source Type: None
DOI: 10.4103/1319-2442.111019 Document Type: Article |
Times cited : (15)
|
References (0)
|